Trial intelligence / Profile preview

Somatropin Treatment in Children with Intrauterine Growth Retardation

NCT01697644Phase 4Completed

Sponsor
Novo Nordisk
Start
Oct 1990
Primary completion
May 2005
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of somatropin in Small for gestational age (SGA), Intrauterine Growth Restriction (IUGR), sponsored by Novo Nordisk. Started Oct 1990; status: completed.

02

Drugs

somatropin
03

Conditions

Small for gestational age (SGA)Intrauterine Growth Restriction (IUGR)

Beyond the preview

Go deeper on NCT01697644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01697644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call